Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00146744
Status:
COMPLETED
Last Update Posted:
2017-05-30
First Post:
2005-09-06
Brief Title:
Safety and Immunogenicity of GSK Biologicals Candidate Tuberculosis Vaccine Mtb72FAS02A in Healthy PPD-positive Adults
Sponsor:
Organization:
GlaxoSmithKline